National Institute of Allergy and Infectious Diseases-Universal Influenza Vaccine

Objective

Improving knowledge of transmission, natural history and pathogenesis of influenza infection to help understand factors that contribute to the spread, severity and diversity of influenza, and to identify measures to improve disease control. Characterizing influenza immunity and immune correlates of protection through the study of immune responses to natural influenza infection and vaccination over time that can be used to identify measurable immune factors critical to vaccine design. Supporting rational design of universal influenza vaccines through the development and iterative clinical testing of immunogens, adjuvants, and alternative vaccine delivery methods.

Who Can Apply

• For-Profit Organization
• Not-for-Profit Organization
• U.S. State Government (including the District of Columbia)
• Federally Recognized Indian/Native American/Alaska Native Tribal Government
• Indian/Native American/Alaska Native Tribal Government (Other than Federally Recognized)
• Tribally Designated Housing Authority
• Municipality or Township government (inclusive of cities, towns, boroughs (except in Alaska), and villages)
• County Government (inclusive of boroughs in Alaska, parishes and other governmental entities with geographic regional control and authority)
• School District Government
• Foreign Non-Governmental For-Profit Organization
• Foreign Non-Government Nonprofit Organization

Assistance Types

• Grant
• Cooperative Agreement

Program Contact

kevin.richardson@nih.gov
3017617870